| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |